JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/19.07.24 Stock

Warrant

DE000JK8U306

Market Closed - Börse Stuttgart 05:26:37 2024-07-12 am EDT
0.41 EUR -18.00% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/19.07.24
Current month+2.50%
1 month-8.89%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 0.41 -18.00%
24-07-11 0.5 -21.88%
24-07-10 0.64 +36.17%
24-07-09 0.47 +30.56%
24-07-08 0.36 -10.00%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 05:26 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JK8U30
ISINDE000JK8U306
Date issued 2024-05-10
Strike 225 $
Maturity 2024-07-19 (7 Days)
Parity 10 : 1
Emission price 0.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1
Lowest since issue 0.22
Spread 0.09
Spread %28.13%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
229.1 USD
Average target price
277.8 USD
Spread / Average Target
+21.26%
Consensus